Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
Eshan U. Patel(Johns Hopkins University), Oliver Laeyendecker(Johns Hopkins University), Yolanda Eby(Johns Hopkins University), Owen R. Baker(National Institutes of Health), Richard E. Rothman(Rush University Medical Center), Thomas C. Quinn(Johns Hopkins University), Ethan Klock(Johns Hopkins University), Evan M. Bloch(Johns Hopkins University), Estelle Piwowar‐Manning(Johns Hopkins University), David Sullivan(Johns Hopkins University), H Schmidt(Johns Hopkins University), Ruchee Shrestha(Johns Hopkins University), Denali Boon(Johns Hopkins University), Shmuel Shoham(Office of Infectious Diseases), Morgan Keruly(Johns Hopkins University), Yu‐Hsiang Hsieh(Johns Hopkins University), Kirsten Littlefield, Andrew Pekosz(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Reinaldo E. Fernández(Johns Hopkins University), Charles Kirby(Johns Hopkins University), Philip A. Sullivan(Johns Hopkins University), Arturo Casadevall(Johns Hopkins University), Andrew D. Redd(Johns Hopkins University), Jernelle Miller(Johns Hopkins University), William Clarke(Johns Hopkins University)
Cited by 198
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
|Nature Reviews Microbiology|2015|1.3k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k
The Natural History of Hepatitis C Virus Infection
|JAMA|2000|1.1k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k